All nursing home staff in Massachusetts must get COVID-19 shots
By
Alicia Lasek
Aug 05, 2021
The state is requiring staff and contract employees in all of its 378 facilities to receive a vaccination, Gov. Charlie Baker announced Wednesday.
CDC director: Agency working to ensure flu vaccine availability
By
Alicia Lasek
Jun 04, 2020
The agency is working with drugmakers to help head off what it says could be an overwhelming wave of flu and COVID-19 infections this fall.
Fauci: Early data show omicron spreads quickly but with less severity than delta
By
Alicia Lasek
Dec 08, 2021
Omicron cases appear to have led to fewer hospitalizations and patients have been less likely to need oxygen, the White House’s infectious disease expert said Tuesday.
Alzheimer’s drug donanemab finds late-stage trial success, safety concerns
By
Alicia Lasek
May 04, 2023
The experimental drug donanemab appears to halt the progression of Alzheimer’s disease and slow certain measures of clinical decline, new trial data show.
Hip fracture readmissions lower when nursing home in sync with hospital staff: study
By
Alicia Lasek
Apr 14, 2022
A collaboration between nursing home staff and hospital clinicians helped reduce readmission and mortality rates and improved quality of life for residents with hip fracture.
Low-dose brain radiation improves behavior, cognition in Alzheimer’s pilot study
By
Alicia Lasek
May 04, 2021
Low-dose ionizing radiation may be a promising, although possibly controversial, therapy for Alzheimer’s disease, according to the researchers behind a small new pilot study.
Survey: U.S. neurologists would prescribe Leqembi if fully approved
By
Alicia Lasek
Apr 12, 2023
A “healthy proportion” of surveyed neurologists have already begun prescribing the treatment, and nearly all said they planned to do so if traditional FDA approval is granted.
Becerra orders CMS to rethink $22 Medicare Part B premium price hike tied to Aduhelm
By
Alicia Lasek
Jan 11, 2022
With the 50% price drop of Aduhelm on January 1, there is good reason for CMS to reassess a hefty proposed premium hike for 2022, the U.S. health secretary said. On Wednesday, CMS is expected to announce...
Benefits of Alzheimer’s drug Leqembi persist when treatment is halted, trial shows
By
Alicia Lasek
Apr 09, 2023
A relative slowing of cognitive decline continues for up to two years in patients who stop taking the recently authorized drug, clinical trial data reveal.
Program that diagnosed fractures virtually led to fewer ER visits for LTC residents: study
By
Alicia Lasek
May 14, 2023
A program that enabled virtual diagnosis and on-site fracture care kept 100% of participating LTC residents out of the emergency department and cut the need for clinic visits, a new study reveals.